NEW YORK (TheStreet) -- Shares of Bayer AG (BAYRY) are higher by 3.94% to $135.20 after it was reported that the pharmaceutical and chemicals company is exploring a sale of its $10 billion plastics unit to focus on expanding the health business, sources say, according to Bloomberg.
The German company is considering the options for Bayer Material Science after Evonik Industries AG showed potential interest several months ago, sources added.
No final decision has been made on the plastics unit, and the Evonik considerations failed to gain traction, they said, Bloomberg noted.
Also, Bayer first quarter earnings before interest, taxes, depreciation, amortization and special items jumped to 2.74 billion euros, beating the 2.56 billion-euro average estimate compiled by Bloomberg.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts